Abstract
The first examples of selective ortho-directed C-H activation with unprotected 2-aryltetrazoles are described. A new base-assisted protocol for iridium (I) hydrogen isotope exchange catalysis allows access to ortho-deuterated and tritiated tetrazoles, including the tetrazole-containing pharmaceutical, Valsartan. Preliminary mechanistic studies are also presented.
Original language | English |
---|---|
Pages (from-to) | 6669-6672 |
Number of pages | 4 |
Journal | Chemical Communications |
Volume | 52 |
Issue number | 40 |
Early online date | 20 Apr 2016 |
DOIs | |
Publication status | E-pub ahead of print - 20 Apr 2016 |
Keywords
- iridium (I) hydrogen isotope exchange catalysis
- ortho-directed C-H activation
- 2-aryltetrazoles